Comparative effects of enarapril versus losartan on the prevention of diabetic nephropathy in type 2 diabetes patients with microalbuminuri
WOS: 000341298100018PubMed ID: 25010195Hyperglycemia, hypertension, dyslipidemia, and inflammation h...
Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with type 2 diabe...
Purpose: To investigate the dual effect of angiotensin blockade by irbesartan and enalapril on prote...
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics w...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient
To examine the effect of low-dose losartan, an angiotensin II antagonist, on persistent microalbumin...
WOS: 000346268700003PubMed ID: 24941431Background: One of the major concerns is a nephropathy in dia...
Background: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of th...
Background Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the...
Abstract The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) st...
Chronic renal failure (CRF) is almost always associated with high arterial blood pressure. Adequate ...
Abstract: Background and purpose: The diabetic nephropathy is one of final stage causes of renal dis...
shown antiproteinuric effects in normotensive and hypertensive diabetic patients. Angiotensin-recept...
Background: Beneficial effect in reducing microalbuminuria of diabetic nephropathy with angiotensin ...
Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in normotens...
WOS: 000341298100018PubMed ID: 25010195Hyperglycemia, hypertension, dyslipidemia, and inflammation h...
Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with type 2 diabe...
Purpose: To investigate the dual effect of angiotensin blockade by irbesartan and enalapril on prote...
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics w...
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patient
To examine the effect of low-dose losartan, an angiotensin II antagonist, on persistent microalbumin...
WOS: 000346268700003PubMed ID: 24941431Background: One of the major concerns is a nephropathy in dia...
Background: Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of th...
Background Diabetic nephropathy is the leading cause of end-stage renal disease. Interruption of the...
Abstract The RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan) st...
Chronic renal failure (CRF) is almost always associated with high arterial blood pressure. Adequate ...
Abstract: Background and purpose: The diabetic nephropathy is one of final stage causes of renal dis...
shown antiproteinuric effects in normotensive and hypertensive diabetic patients. Angiotensin-recept...
Background: Beneficial effect in reducing microalbuminuria of diabetic nephropathy with angiotensin ...
Background: Angiotensin-converting enzyme inhibitors have shown antiproteinuric effects in normotens...
WOS: 000341298100018PubMed ID: 25010195Hyperglycemia, hypertension, dyslipidemia, and inflammation h...
Angiotensin receptor blockers are renoprotective in hypertensive azotemic patients with type 2 diabe...
Purpose: To investigate the dual effect of angiotensin blockade by irbesartan and enalapril on prote...